Skip to main content
. 2020 Mar 26;8(1):e000538. doi: 10.1136/jitc-2020-000538

Figure 2.

Figure 2

Swimmers plot denoting time on checkpoint inhibitors (CPI) treatment in patients with (A) renal cell carcinoma and (B) urothelial carcinoma with pre-existing autoimmune disorder (AD) with time to onset of AD exacerbation and/or new immune-related adverse event (irAE) and time of CPI discontinuation.